secwatch.observer — SEC 8-K summary
======================================

Issuer:     Glucotrack, Inc. (GCTK)
CIK:        0001506983
Form:       8-K
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001493152-23-031074
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GlucoTrack appoints Erin Carter as director and Audit Committee Chair
---------------------------------------------------------------------

- Erin Carter appointed director and Audit Committee Chair effective August 25, 2023.
- Carter brings 30 years of med device finance experience; was CFO of Medtronic's $9B Neuroscience division.
- She replaces Shimon Rapps, who remains as a member of the Audit Committee.
- Carter previously held senior finance roles at Boston Scientific, UnitedHealth Group, and Arterial Vascular Engineering.
- Board cites her executive finance experience and life science leadership as qualifications.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506983/000149315223031074/0001493152-23-031074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506983/000149315223031074/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-031074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer